Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:23 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 288,593 9.990% | 288,593 (New Position) | Filing History |
| 2024-02-14 1:53 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Alyeska Investment Group, L.P. | 287,071 9.990% | 287,071 (New Position) | Filing History |
| 2024-02-08 5:44 pm Unchanged | 2023-11-02 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI L.P. | 58,317 1.900% | 0 (Unchanged) | Filing History |
| 2023-11-07 5:16 pm Purchase | 2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS | Roche Finance Ltd | 441,038 15.350% | 317,344 (+256.56%) | Filing History |
| 2023-11-06 4:05 pm Purchase | 2023-10-25 | 13D | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 155,530 5.300% | 48,411 (+45.19%) | Filing History |
| 2023-11-02 4:08 pm Purchase | 2023-10-23 | 13G | Aligos Therapeutics, Inc. ALGS | Deep Track Biotechnology Master Fund, Ltd. | 291,839 9.990% | 291,839 (New Position) | Filing History |
| 2023-02-14 4:10 pm Sale | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR ADVISORS LTD. | 92,391 5.800% | -2,212 (-2.34%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | TANG CAPITAL PARTNERS LP | 112,656 7.100% | 18,300 (+19.39%) | Filing History |
| 2023-02-13 08:25 am Purchase | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 157,934 9.900% | 29,402 (+22.88%) | Filing History |
| 2023-02-09 10:34 am Sale | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -96,785 (Position Closed) | Filing History |
| 2023-02-08 4:58 pm Purchase | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 107,119 6.500% | 6,744 (+6.72%) | Filing History |
| 2022-12-27 5:06 pm Purchase | 2022-12-16 | 13G | Aligos Therapeutics, Inc. ALGS | TANG CAPITAL PARTNERS LP | 94,356 5.900% | 94,356 (New Position) | Filing History |
| 2022-02-14 4:55 pm Purchase | 2022-02-04 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 128,532 7.500% | 128,532 (New Position) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Logos Global Management LP | 0 0.000% | -114,911 (Position Closed) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BAKER BROS. ADVISORS LP | 83,056 5.300% | 83,056 (New Position) | Filing History |
| 2022-02-14 4:08 pm Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR ADVISORS LTD. | 94,603 5.600% | 8,000 (+9.24%) | Filing History |
| 2022-02-14 08:20 am Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | JANUS HENDERSON GROUP PLC JHG | 96,785 5.700% | 96,785 (New Position) | Filing History |
| 2022-02-10 4:19 pm Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Beigelman Leonid | 74,894 4.700% | 3,000 (+4.17%) | Filing History |
| 2022-02-10 4:15 pm Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 100,375 6.200% | 4,500 (+4.69%) | Filing History |
| 2022-02-10 07:48 am Sale | 2022-01-31 | 13G | Aligos Therapeutics, Inc. ALGS | Wellington Management Group LLP | 52,173 3.060% | -90,306 (-63.38%) | Filing History |